A multi-stage virtual screening of FDA-approved drugs reveals potential inhibitors of SARS-CoV-2 main protease

References

• Alaraby Salem, M., & Brown, A. (2015). Two-photon absorption of fluorescent protein chromophores incorporating non-canonical amino acids: TD-DFT screening and classical dynamics. Physical Chemistry Chemical Physics: PCCP, 17(38), 25563–25571. https://doi.org/https://doi.org/10.1039/c5cp03875h
   PubMed Web of Science ®Google Scholar
• Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J. R., & Hilgenfeld, R. (2003). Coronavirus main proteinase (3CLpro) structure: Basis for design of anti-SARS drugs. Science (New York, N.Y.), 300(5626), 1763–1767. https://doi.org/https://doi.org/10.1126/science.1085658
   PubMed Web of Science ®Google Scholar
• Ancy, I., Sivanandam, M., & Kumaradhas, P. (2020). Possibility of HIV-1 protease inhibitors-clinical trial drugs as repurposed drugs for SARS-CoV-2 main protease: A molecular docking, molecular dynamics and binding free energy simulation study. Journal of Biomolecular Structure and Dynamics, 1–8. https://doi.org/https://doi.org/10.1080/07391102.2020.1786459
   Web of Science ®Google Scholar
• Anighoro, A., & Bajorath, J. (2016a). Binding mode similarity measures for ranking of docking poses: A case study on the adenosine A2A receptor. Journal of Computer-Aided Molecular Design, 30(6), 447–456. https://doi.org/https://doi.org/10.1007/s10822-016-9918-z
   PubMed Web of Science ®Google Scholar
• Anighoro, A., & Bajorath, J. (2016b). Three-dimensional similarity in molecular docking: Prioritizing ligand poses on the basis of experimental binding modes. Journal of Chemical Information and Modeling, 56(3), 580–587. https://doi.org/https://doi.org/10.1021/acs.jcim.5b00745
   PubMed Web of Science ®Google Scholar
• Aouidate, A., Ghaleb, A., Chtita, S., Aarjane, M., Ousaa, A., Maghat, H., Sbai, A., Choukrad, M. b., Bouachrine, M., & Lakhlifi, T. (2020). Identification of a novel dual-target scaffold for 3CLpro and RdRp proteins of SARS-CoV-2 using 3D-similarity search, molecular docking, molecular dynamics and ADMET evaluation. Journal of Biomolecular Structure and Dynamics, 1–14. https://doi.org/https://doi.org/10.1080/07391102.2020.1779130
   Google Scholar
• Arun, K. G., Sharanya, C. S., Abhithaj, J., Francis, D., & Sadasivan, C. (2020). Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target. Journal of Biomolecular Structure and Dynamics, 1–12. https://doi.org/https://doi.org/10.1080/07391102.2020.1779819
   Google Scholar
• Bacha, U., Barrila, J., Velazquez-Campoy, A., Leavitt, S. A., & Freire, E. (2004). Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro. Biochemistry, 43(17), 4906–4912. https://doi.org/https://doi.org/10.1021/bi0361766
   PubMed Web of Science ®Google Scholar
• Bailey, O. T., Pappenheimer, A. M., Cheever, F. S., & Daniels, J. B. (1949). A murine virus (Jhm) causing disseminated encephalomyelitis with extensive destruction of myelin: II. Pathology. The Journal of Experimental Medicine, 90(3), 195–212. https://doi.org/https://doi.org/10.1084/jem.90.3.195
   PubMed Web of Science ®Google Scholar
• Barretto, N., Jukneliene, D., Ratia, K., Chen, Z., Mesecar, A. D., & Baker, S. C. (2005). The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity. Journal of Virology, 79(24), 15189–15198.https://doi.org/https://doi.org/10.1128/JVI.79.24.15189-15198.2005
   PubMed Web of Science ®Google Scholar
• Bartlam, M., Xu, Y., & Rao, Z. (2007). Structural proteomics of the SARS coronavirus: A model response to emerging infectious diseases. Journal of Structural and Functional Genomics, 8(2–3), 85–97. https://doi.org/https://doi.org/10.1007/s10969-007-9024-5
   PubMedGoogle Scholar
• Bégué, J.-P., & Bonnet-Delpon, D. (1991). Preparation of trifluoromethyl ketones and related fluorinated ketones. Tetrahedron, 47(20–21), 3207–3258. https://doi.org/https://doi.org/10.1016/S0040-4020(01)86391-2
   Web of Science ®Google Scholar
• Chatterjee, S., Maity, A., Chowdhury, S., Islam, M. A., Muttinini, R. K., & Sen, D. (2020). In silico analysis and identification of promising hits against 2019 novel coronavirus 3C-like main protease enzyme. Journal of Biomolecular Structure and Dynamics, 1–14. https://doi.org/https://doi.org/10.1080/07391102.2020.1787228
   Google Scholar
• Chen, L., Li, J., Luo, C., Liu, H., Xu, W., Chen, G., Liew, O. W., Zhu, W., Puah, C. M., Shen, X., & Jiang, H. (2006). Binding interaction of quercetin-3-beta-galactoside and its synthetic derivatives with SARS-CoV 3CL(pro): Structure-activity relationship studies reveal salient pharmacophore features. Bioorganic & Medicinal Chemistry, 14(24), 8295–8306. https://doi.org/https://doi.org/10.1016/j.bmc.2006.09.014
   PubMed Web of Science ®Google Scholar
• Chen, Z. M., Fu, J. F., Shu, Q., Chen, Y. H., Hua, C. Z., Li, F. B., Lin, R., Tang, L. F., Wang, T. L., Wang, W., Wang, Y. S., Xu, W. Z., Yang, Z. H., Ye, S., Yuan, T. M., Zhang, C. M., & Zhang, Y. Y. (2020). Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World Journal of Pediatrics: WJP, 16(3), 240–246. https://doi.org/https://doi.org/10.1007/s12519-020-00345-5
   PubMed Web of Science ®Google Scholar
• Case, D. A., Belfon, K., Ben-Shalom, I. Y., Brozell, S. R., Cerutti, D. S., Cheatham, T. E., Cruzeiro III, V. W. D., Darden, T. A., Duke, R. E., Giambasu, G., Gilson, M. K., Gohlke, H., Goetz, A. W., Harris, R., Izadi, S., Izmailov, S. A., Kasavajhala, K., Kovalenko, A., Krasny, R., … Kollman, P. A. (2020). Amber 12, University of California.
   Google Scholar
• Da, C., & Kireev, D. (2014). Structural protein-ligand interaction fingerprints (SPLIF) for structure-based virtual screening: Method and benchmark study. Journal of Chemical Information and Modeling, 54(9), 2555–2561. https://doi.org/https://doi.org/10.1021/ci500319f
   PubMed Web of Science ®Google Scholar
• Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems. The Journal of Chemical Physics, 98(12), 10089–10092. https://doi.org/https://doi.org/10.1063/1.464397
   Web of Science ®Google Scholar
• Drosten, C., Gunther, S., Preiser, W., van der Werf, S., Brodt, H. R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A., Berger, A., Burguiere, A. M., Cinatl, J., Eickmann, M., Escriou, N., Grywna, K., Kramme, S., Manuguerra, J. C., Muller, S., … Doerr, H. W. (2003). Identification of a novel coronavirus in patients with severe acute respiratory syndrome. The New England Journal of Medicine, 348(20), 1967–1976. https://doi.org/https://doi.org/10.1056/NEJMoa030747
   PubMed Web of Science ®Google Scholar
• Elmezayen, A. D., Al-Obaidi, A., Şahin, A. T., & Yelekçi, K. (2020). Drug repurposing for coronavirus (COVID-19): In silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. Journal of Biomolecular Structure and Dynamics, 1–13. https://doi.org/https://doi.org/10.1080/07391102.2020.1758791
   Web of Science ®Google Scholar
• Food and Drug Administration (FDA). (2020). Retrieved May 3, 2020, from https://www.fda.gov/media/137564/download
   Google Scholar
• Gelb, M. H., Svaren, J. P., & Abeles, R. H. (1985). Fluoro ketone inhibitors of hydrolytic enzymes. Biochemistry, 24(8), 1813–1817. https://doi.org/https://doi.org/10.1021/bi00329a001
   PubMed Web of Science ®Google Scholar
• Genheden, S., & Ryde, U. (2015). The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opinion on Drug Discovery, 10(5), 449–461. https://doi.org/https://doi.org/10.1517/17460441.2015.1032936
   PubMed Web of Science ®Google Scholar
• Hilgenfeld, R. (2014). From SARS to MERS: Crystallographic studies on coronaviral proteases enable antiviral drug design. The FEBS Journal, 281(18), 4085–4096. https://doi.org/https://doi.org/10.1111/febs.12936
   PubMed Web of Science ®Google Scholar
• Homeyer, N., & Gohlke, H. (2012). Free energy calculations by the molecular mechanics poisson-boltzmann surface area method. Molecular Informatics, 31(2), 114–122. https://doi.org/https://doi.org/10.1002/minf.201100135
   PubMed Web of Science ®Google Scholar
• Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14(1), 33–38, 27-38. https://doi.org/https://doi.org/10.1016/0263-7855(96)00018-5
   PubMedGoogle Scholar
• Jacobs, J., Grum-Tokars, V., Zhou, Y., Turlington, M., Saldanha, S. A., Chase, P., Eggler, A., Dawson, E. S., Baez-Santos, Y. M., Tomar, S., Mielech, A. M., Baker, S. C., Lindsley, C. W., Hodder, P., Mesecar, A., & Stauffer, S. R. (2013). Discovery, synthesis, and structure-based optimization of a series of N-(tert-butyl)-2-(N-arylamido)-2-(pyridin-3-yl) acetamides (ML188) as potent noncovalent small molecule inhibitors of the severe acute respiratory syndrome coronavirus (SARS-CoV) 3CL protease. Journal of Medicinal Chemistry, 56(2), 534–546. https://doi.org/https://doi.org/10.1021/jm301580n
   PubMed Web of Science ®Google Scholar
• Jain, R. P., Pettersson, H. I., Zhang, J., Aull, K. D., Fortin, P. D., Huitema, C., Eltis, L. D., Parrish, J. C., James, M. N., Wishart, D. S., & Vederas, J. C. (2004). Synthesis and evaluation of keto-glutamine analogues as potent inhibitors of severe acute respiratory syndrome 3CLpro. Journal of Medicinal Chemistry, 47(25), 6113–6116. https://doi.org/https://doi.org/10.1021/jm0494873
   PubMed Web of Science ®Google Scholar
• Jenwitheesuk, E., & Samudrala, R. (2003). Identifying inhibitors of the SARS coronavirus proteinase. Bioorganic & Medicinal Chemistry Letters, 13(22), 3989–3992. https://doi.org/https://doi.org/10.1016/j.bmcl.2003.08.066
   PubMed Web of Science ®Google Scholar
• Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., Duan, Y., Yu, J., Wang, L., Yang, K., Liu, F., Jiang, R., Yang, X., You, T., Liu, X., … Yang, H. (2020). Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature, 582(7811), 289–293. https://doi.org/https://doi.org/10.1038/s41586-020-2223-y
   PubMed Web of Science ®Google Scholar
• Jones, G., Willett, P., & Glen, R. C. (1995). Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. Journal of Molecular Biology, 245(1), 43–53. https://doi.org/https://doi.org/10.1016/S0022-2836(95)80037-9
   PubMed Web of Science ®Google Scholar
• Jones, G., Willett, P., Glen, R. C., Leach, A. R., & Taylor, R. (1997). Development and validation of a genetic algorithm for flexible docking. Journal of Molecular Biology, 267(3), 727–748. https://doi.org/https://doi.org/10.1006/jmbi.1996.0897
   PubMed Web of Science ®Google Scholar
• Khan, R. J., Jha, R. K., Amera, G. M., Jain, M., Singh, E., Pathak, A., Singh, R. P., Muthukumaran, J., & Singh, A. K. (2020). Targeting SARS-CoV-2: A systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2′-O-ribose methyltransferase. Journal of Biomolecular Structure and Dynamics, 1–14. https://doi.org/https://doi.org/10.1080/07391102.2020.1753577
   Google Scholar
• Kumar, D., Kumari, K., Vishvakarma, V. K., Jayaraj, A., Kumar, D., Ramappa, V. K., Patel, R., Kumar, V., Dass, S. K., Chandra, R., & Singh, P. (2020). Promising inhibitors of main protease of novel corona virus to prevent the spread of COVID-19 using docking and molecular dynamics simulation. Journal of Biomolecular Structure and Dynamics, 1–15. https://doi.org/https://doi.org/10.1080/07391102.2020.1779131
   Google Scholar
• Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., Xing, X., Xiang, N., Wu, Y., Li, C., Chen, Q., Li, D., Liu, T., Zhao, J., Liu, M., … Feng, Z. (2020). Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. The New England Journal of Medicine, 382(13), 1199–1207. https://doi.org/https://doi.org/10.1056/NEJMoa2001316
   PubMed Web of Science ®Google Scholar
• Loncharich, R. J., Brooks, B. R., & Pastor, R. W. (1992). Langevin dynamics of peptides: The frictional dependence of isomerization rates of N-acetylalanyl-N'-methylamide. Biopolymers, 32(5), 523–535. https://doi.org/https://doi.org/10.1002/bip.360320508
   PubMed Web of Science ®Google Scholar
• Ma, C., Sacco, M. D., Hurst, B., Townsend, J. A., Hu, Y., Szeto, T., Zhang, X., Tarbet, B., Marty, M. T., Chen, Y., & Wang, J. (2020). Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease. Cell Research, 30(8), 678–692. https://doi.org/https://doi.org/10.1038/s41422-020-0356-z
   PubMed Web of Science ®Google Scholar
• Mesecar, A. D. (2020). A taxonomically-driven approach to development of potent, broad-spectrum inhibitors of coronavirus main protease including SARS-CoV-2 (COVID-19). https://doi.org/https://doi.org/10.2210/pdb6W63/pdb
   Google Scholar
• Miller, B. R., 3rd, McGee, T. D., Jr., Swails, J. M., Homeyer, N., Gohlke, H., & Roitberg, A. E. (2012). MMPBSA.py: An efficient program for end-state free energy calculations. Journal of Chemical Theory and Computation, 8(9), 3314–3321. https://doi.org/https://doi.org/10.1021/ct300418h
   PubMed Web of Science ®Google Scholar
• Molecular Operating Environment (MOE). (2019). 2019.01, Chemical Computing Group ULC, 1010 Sherbrooke St. West, Suite #910, Montreal, QC, Canada, H3A 2R7.
   Google Scholar
• Mysinger, M. M., Carchia, M., Irwin, J. J., & Shoichet, B. K. (2012). Directory of useful decoys, enhanced (DUD-E): Better ligands and decoys for better benchmarking. Journal of Medicinal Chemistry, 55(14), 6582–6594. https://doi.org/https://doi.org/10.1021/jm300687e
   PubMed Web of Science ®Google Scholar
• Neudert, G., & Klebe, G. (2011). DSX: A knowledge-based scoring function for the assessment of protein-ligand complexes. Journal of Chemical Information and Modeling, 51(10), 2731–2745. https://doi.org/https://doi.org/10.1021/ci200274q
   PubMed Web of Science ®Google Scholar
• Payne, S. (2017). Chapter 17- Family coronaviridae. In S. Payne (Ed.), Viruses (pp.149–158). Academic Press. https://doi.org/https://doi.org/10.1016/B978-0-12-803109-4.00017-9
   PubMedGoogle Scholar
• Roe, D. R., & Cheatham, T. E. 3rd. (2013). PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data. Journal of Chemical Theory and Computation, 9(7), 3084–3095. https://doi.org/https://doi.org/10.1021/ct400341p
   PubMed Web of Science ®Google Scholar
• Rota, P. A., Oberste, M. S., Monroe, S. S., Nix, W. A., Campagnoli, R., Icenogle, J. P., Penaranda, S., Bankamp, B., Maher, K., Chen, M. H., Tong, S., Tamin, A., Lowe, L., Frace, M., DeRisi, J. L., Chen, Q., Wang, D., Erdman, D. D., Peret, T. C., … Bellini, W. J. (2003). Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science (New York, N.Y.), 300(5624), 1394–1399. https://doi.org/https://doi.org/10.1126/science.1085952
   PubMed Web of Science ®Google Scholar
• Schrodinger, LLC. (2015). The PyMOL Molecular Graphics System, Version 1.8.
   Google Scholar
• Shao, Y. M., Yang, W. B., Kuo, T. H., Tsai, K. C., Lin, C. H., Yang, A. S., Liang, P. H., & Wong, C. H. (2008). Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease. Bioorganic & Medicinal Chemistry, 16(8), 4652–4660. https://doi.org/https://doi.org/10.1016/j.bmc.2008.02.040
   PubMed Web of Science ®Google Scholar
• Shie, J. J., Fang, J. M., Kuo, C. J., Kuo, T. H., Liang, P. H., Huang, H. J., Yang, W. B., Lin, C. H., Chen, J. L., Wu, Y. T., & Wong, C. H. (2005). Discovery of potent anilide inhibitors against the severe acute respiratory syndrome 3CL protease. Journal of Medicinal Chemistry, 48(13), 4469–4473. https://doi.org/https://doi.org/10.1021/jm050184y
   PubMed Web of Science ®Google Scholar
• Shimamoto, Y., Hattori, Y., Kobayashi, K., Teruya, K., Sanjoh, A., Nakagawa, A., Yamashita, E., & Akaji, K. (2015). Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CL protease inhibitors. Bioorganic & Medicinal Chemistry, 23(4), 876–890. https://doi.org/https://doi.org/10.1016/j.bmc.2014.12.028
   PubMed Web of Science ®Google Scholar
• Thanigaimalai, P., Konno, S., Yamamoto, T., Koiwai, Y., Taguchi, A., Takayama, K., Yakushiji, F., Akaji, K., Chen, S. E., Naser-Tavakolian, A., Schon, A., Freire, E., & Hayashi, Y. (2013). Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: Design, synthesis, biological evaluation, and docking studies. European Journal of Medicinal Chemistry, 68, 372–384. https://doi.org/https://doi.org/10.1016/j.ejmech.2013.07.037
   PubMed Web of Science ®Google Scholar
• Thanigaimalai, P., Konno, S., Yamamoto, T., Koiwai, Y., Taguchi, A., Takayama, K., Yakushiji, F., Akaji, K., Kiso, Y., Kawasaki, Y., Chen, S. E., Naser-Tavakolian, A., Schon, A., Freire, E., & Hayashi, Y. (2013). Design, synthesis, and biological evaluation of novel dipeptide-type SARS-CoV 3CL protease inhibitors: Structure-activity relationship study. European Journal of Medicinal Chemistry, 65, 436–447. https://doi.org/https://doi.org/10.1016/j.ejmech.2013.05.005
   PubMed Web of Science ®Google Scholar
• Tomlinson, S. M., & Watowich, S. J. (2011). Anthracene-based inhibitors of dengue virus NS2B-NS3 protease. Antiviral Research, 89(2), 127–135. https://doi.org/https://doi.org/10.1016/j.antiviral.2010.12.006
   PubMed Web of Science ®Google Scholar
• Turlington, M., Chun, A., Tomar, S., Eggler, A., Grum-Tokars, V., Jacobs, J., Daniels, J. S., Dawson, E., Saldanha, A., Chase, P., Baez-Santos, Y. M., Lindsley, C. W., Hodder, P., Mesecar, A. D., & Stauffer, S. R. (2013). Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: Identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding. Bioorganic & Medicinal Chemistry Letters, 23(22), 6172–6177. https://doi.org/https://doi.org/10.1016/j.bmcl.2013.08.112
   PubMed Web of Science ®Google Scholar
• Turner, P. J. (2005). XMGRACE (Version 5.1.19). Beaverton, OR: Center for Coastal and Land-Margin Research, Oregon Graduate Institute of Science and Technology.
   Google Scholar
• Wang, F., Chen, C., Tan, W., Yang, K., & Yang, H. (2016). Structure of main protease from human coronavirus NL63: Insights for wide spectrum anti-coronavirus drug design. Scientific Reports, 6, 22677 https://doi.org/https://doi.org/10.1038/srep22677
   PubMed Web of Science ®Google Scholar
• Wang, J. (2020). Fast Identification of possible drug treatment of coronavirus disease-19 (COVID-19) through computational drug repurposing study. Journal of Chemical Information and Modeling, 60(6), 3277–3286. https://doi.org/https://doi.org/10.1021/acs.jcim.0c00179
   PubMed Web of Science ®Google Scholar
• Wang, J., Ge, Y., & Xie, X. Q. (2019). Development and testing of druglike screening libraries. Journal of Chemical Information and Modeling, 59(1), 53–65. https://doi.org/https://doi.org/10.1021/acs.jcim.8b00537
   PubMed Web of Science ®Google Scholar
• Wang, J., Wang, W., Kollman, P. A., & Case, D. A. (2006). Automatic atom type and bond type perception in molecular mechanical calculations. Journal of Molecular Graphics & Modelling, 25(2), 247–260. https://doi.org/https://doi.org/10.1016/j.jmgm.2005.12.005
   PubMed Web of Science ®Google Scholar
• Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A., & Case, D. A. (2004). Development and testing of a general amber force field. Journal of Computational Chemistry, 25(9), 1157–1174. https://doi.org/https://doi.org/10.1002/jcc.20035
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). (2020). Timeline of WHO’s response to COVID-19. Retrieved July 24, 2020, from http://www.who.int/
   Google Scholar
• Word, J. M., Lovell, S. C., Richardson, J. S., & Richardson, D. C. (1999). Asparagine and glutamine: Using hydrogen atom contacts in the choice of side-chain amide orientation. Journal of Molecular Biology, 285(4), 1735–1747. https://doi.org/https://doi.org/10.1006/jmbi.1998.2401
   PubMed Web of Science ®Google Scholar
• Xu, X., Chen, P., Wang, J., Feng, J., Zhou, H., Li, X., Zhong, W., & Hao, P. (2020). Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Science China. Life Sciences, 63(3), 457–460. https://doi.org/https://doi.org/10.1007/s11427-020-1637-5
   PubMed Web of Science ®Google Scholar
• Xue, X., Yu, H., Yang, H., Xue, F., Wu, Z., Shen, W., Li, J., Zhou, Z., Ding, Y., Zhao, Q., Zhang, X. C., Liao, M., Bartlam, M., & Rao, Z. (2008). Structures of two coronavirus main proteases: implications for substrate binding and antiviral drug design. Journal of Virology, 82(5), 2515–2527. https://doi.org/https://doi.org/10.1128/JVI.02114-07
   PubMed Web of Science ®Google Scholar
• Yang, H., Yang, M., Ding, Y., Liu, Y., Lou, Z., Zhou, Z., Sun, L., Mo, L., Ye, S., Pang, H., Gao, G. F., Anand, K., Bartlam, M., Hilgenfeld, R., & Rao, Z. (2003). The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proceedings of the National Academy of Sciences of the United States of America, 100(23), 13190–13195. https://doi.org/https://doi.org/10.1073/pnas.1835675100
   PubMed Web of Science ®Google Scholar
• Yi, L., Li, Z., Yuan, K., Qu, X., Chen, J., Wang, G., Zhang, H., Luo, H., Zhu, L., Jiang, P., Chen, L., Shen, Y., Luo, M., Zuo, G., Hu, J., Duan, D., Nie, Y., Shi, X., Wang, W., … Xu, X. (2004). Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells. Journal of Virology, 78(20), 11334–11339. https://doi.org/https://doi.org/10.1128/JVI.78.20.11334-11339.2004
   PubMed Web of Science ®Google Scholar
• Zhang, H. Z., Zhang, H., Kemnitzer, W., Tseng, B., Cinatl, J., Jr., Michaelis, M., Doerr, H. W., & Cai, S. X. (2006). Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors. Journal of Medicinal Chemistry, 49(3), 1198–1201. https://doi.org/https://doi.org/10.1021/jm0507678
   PubMed Web of Science ®Google Scholar
• Zhang, L., Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., Becker, S., Rox, K., & Hilgenfeld, R. (2020). Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors. Science, 368(6489), 409–412. https://doi.org/https://doi.org/10.1126/science.abb3405
   PubMed Web of Science ®Google Scholar
• Zhang, Y. Z., & Holmes, E. C. (2020). A genomic perspective on the origin and emergence of SARS-CoV-2. Cell, 181(2), 223–227. https://doi.org/https://doi.org/10.1016/j.cell.2020.03.035
   PubMed Web of Science ®Google Scholar
• Zhu, L., George, S., Schmidt, M. F., Al-Gharabli, S. I., Rademann, J., & Hilgenfeld, R. (2011). Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease. Antiviral Research, 92(2), 204–212. https://doi.org/https://doi.org/10.1016/j.antiviral.2011.08.001 [InsertedFromOnline[pubmedMismatch]]
   PubMed Web of Science ®Google Scholar